Skip to content

IMNM

Immunome, Inc.

NASDAQ · USHealthcareBiotechnology
$22.16-0.72%

Price as of Jul 20, 2026

IMNM capital

Immunome, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.01x
Net debt / equity
-0.98x
Debt / assets
0.01x
Debt / EBITDA
-0.02x
Net debt / EBITDA
2.61x

Liquidity & coverage

Current ratio
21.68x
Quick ratio
21.68x
Cash ratio
21.26x
Interest coverage
EBITDA / interest
Working capital
$566.9M

Cash & dividend

FCF / debt
-55.64x
Cash flow / debt
-53.19x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.